The largest database of trusted experimental protocols

Anti mouse ifn γ capture antibody

Manufactured by BioLegend
Sourced in United States

Anti-mouse IFN-γ capture antibody is a monoclonal antibody that binds to mouse interferon-gamma (IFN-γ). It can be used to capture IFN-γ in immunoassays.

Automatically generated - may contain errors

3 protocols using anti mouse ifn γ capture antibody

1

IFN-γ ELISpot Assay for Tumor-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon sacrifice, splenocytes from B16F10-sTAC tumor-bearing mice were analyzed for IFN-γ producing cells by enzyme-linked immunosorbent spot (ELISpot) assay. Multiscreen filtration plates (Millipore, MSHAN4550) were coated with 0.5 μg/ml of purified anti-mouse IFN-γ capture antibody (BioLegend) overnight at 4˚C. Single-cell suspensions of splenocytes or tumors were plated at 1×106 per well. Splenocytes were stimulated with the SIINFEKL peptide (Anaspec, AS-60193–1) at 20 μg/ml. After 16 hours of stimulation at 37˚C, the cells were removed by washing and spots were developed with a biotinylated anti-IFN-γ detection antibody (BioLegend) and streptavidin-horseradish peroxidase conjugate followed by NITRO-blue tetrazolium chloride and 5-bromo-4-chloro-3’-indoylphosphate p-toluidine salt substrate (Sigma, B5655–25TAB). Spot numbers were counted, and data were reported as IFN-γ-spot forming cells per 106 cells.
+ Open protocol
+ Expand
2

Quantifying IFN-γ Responses in Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon sacrifice, splenocytes from B16F10-sTAC tumor-bearing mice were analyzed for IFN-γ producing cells by enzyme-linked immunosorbent spot (ELISpot) assay. Multiscreen filtration plates (Millipore, Burlington, MA, USA, MSHAN4550) were coated with 0.5 µg/mL of purified anti-mouse IFN-γ capture antibody (Biolegend, San Diego, CA, USA, 505702) overnight at 4 °C. Single-cell suspensions of splenocytes or tumors were plated at 1 × 106 per well. Splenocytes were stimulated with the SIINFEKL peptide (Anaspec, Fremont, CA, USA, AS-60193-1) at 20 µg/mL. After 16 h of stimulation at 37 °C, the cells were removed by washing and spots were developed with a biotinylated anti-IFN-γ detection antibody (Biolegend, 505804) and streptavidin-horseradish peroxidase conjugate followed by NITRO-blue tetrazolium chloride and 5-bromo-4-chloro-3′-indoylphosphate p-toluidine salt substrate (Sigma, B5655-25TAB). Spot numbers were counted, and data were reported as IFN-γ-spot forming cells per 106 cells.
+ Open protocol
+ Expand
3

ELISpot Assay for Tumor-Specific IFN-γ

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon sacrifice, splenocytes from B16F10-sTAC tumor bearing mice and tumor cell suspensions from CT26.CL25 tumor bearing mice were analyzed for IFN-γ producing cells by enzyme-linked immunosorbent spot (ELISpot) assay. Multiscreen filtration plates (Millipore) were coated with 0.5 μg/mL of purified anti-mouse IFN-γ capture antibody (Biolegend) overnight at 4 °C. Single-cell suspensions of splenocytes or tumors were plated at 1×106 and 5×105 per well respectively. For ELISpot assays with splenocytes from B16F10-sTAC tumor bearing mice, cells were stimulated with the SIINFEKL peptide (Anaspec) at 20 μg/mL. Cells from CT26.CL25 tumors were treated with a known H-2D-restricted β-galactosidase peptide (TPHPARIGL; ChemPep). After 16 hours of stimulation at 37 °C, the cells were removed by washing and spots were developed with a biotinylated anti-IFN-γ detection antibody and streptavidin-horseradish peroxidase conjugate followed by NITRO-blue tetrazolium chloride and 5-bromo-4-chloro-3ʹ-indoylphosphate p-toluidine salt substrate (Sigma). Spot numbers were counted, and data were reported as IFN-γ-spot forming cells per 106 cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!